Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 7 studies | 29% ± 9% | |
endothelial cell | 5 studies | 23% ± 6% | |
epithelial cell | 5 studies | 25% ± 6% | |
astrocyte | 5 studies | 28% ± 10% | |
GABAergic neuron | 4 studies | 48% ± 18% | |
glutamatergic neuron | 4 studies | 56% ± 24% | |
oligodendrocyte precursor cell | 4 studies | 37% ± 10% | |
B cell | 3 studies | 18% ± 4% | |
retina horizontal cell | 3 studies | 22% ± 2% | |
interneuron | 3 studies | 47% ± 25% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 47% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1490.11 | 245 / 245 | 99% | 4.33 | 498 / 502 |
brain | 99% | 1653.81 | 2626 / 2642 | 100% | 5.62 | 703 / 705 |
thymus | 100% | 2247.13 | 653 / 653 | 99% | 5.86 | 597 / 605 |
ovary | 100% | 2843.62 | 180 / 180 | 96% | 4.07 | 414 / 430 |
breast | 100% | 944.13 | 459 / 459 | 95% | 4.35 | 1058 / 1118 |
kidney | 100% | 1092.57 | 89 / 89 | 93% | 3.24 | 837 / 901 |
adrenal gland | 100% | 1166.07 | 258 / 258 | 92% | 2.59 | 211 / 230 |
pancreas | 100% | 1006.93 | 327 / 328 | 85% | 2.19 | 151 / 178 |
stomach | 100% | 896.05 | 359 / 359 | 84% | 2.34 | 241 / 286 |
bladder | 100% | 1115.95 | 21 / 21 | 77% | 2.33 | 387 / 504 |
intestine | 100% | 1049.89 | 966 / 966 | 76% | 1.68 | 399 / 527 |
esophagus | 100% | 961.99 | 1442 / 1445 | 73% | 2.45 | 133 / 183 |
lung | 100% | 1054.03 | 576 / 578 | 73% | 2.47 | 838 / 1155 |
skin | 98% | 596.45 | 1780 / 1809 | 49% | 1.02 | 233 / 472 |
uterus | 100% | 1590.52 | 170 / 170 | 47% | 1.29 | 217 / 459 |
liver | 74% | 273.07 | 168 / 226 | 37% | 0.71 | 150 / 406 |
spleen | 100% | 1399.56 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.11 | 1 / 1 |
blood vessel | 99% | 1138.06 | 1327 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 663.70 | 1192 / 1204 | 0% | 0 | 0 / 0 |
heart | 97% | 699.74 | 835 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 2.36 | 26 / 29 |
muscle | 88% | 429.37 | 710 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 70% | 416.43 | 650 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 43% | 0.83 | 34 / 80 |
tonsil | 0% | 0 | 0 / 0 | 16% | 0.21 | 7 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNF493 |
Protein name | ZNF493 protein Zinc finger protein 493 |
Synonyms | LOC115648 hCG_1780065 |
Description | FUNCTION: May be involved in transcriptional regulation. |
Accessions | ENST00000355504.4 [Q6ZR52-1] ENST00000596302.5 ENST00000339914.6 [Q6ZR52-3] ENST00000594390.5 M0QY95 ENST00000599461.1 Q2M1I7 ENST00000392288.7 [Q6ZR52-2] M0R1U0 Q6ZR52 M0QXT4 ENST00000596815.1 |